Q: Hi Peter,
What is your take on crh, earning after the bell.
Thank you.
What is your take on crh, earning after the bell.
Thank you.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Never fall in love with a stock, this means me and also 5i, since Jan./15 to now this stock has returned app. 10%, if you just bought ZUH, a health care etf, you had a 25% return. I don't what is expected of this stock,if it ever makes a purchase with it's cash, but does someone expect it to just rocket it value. Why not take 5i's advice, most of the time,. and invest in stocks on the rise, than hope that something changes. Too many good stocks out there to own, than this one. Don't try to be smarter than the market. Just my opinion.
Q: in your previous answer to me you said you cannot fault knight for not doing a deal.
my question is can you fault them for raising money over a year ago at about 10 dollars, diluting the stock and then doing nothing with the money, this to me is ripping off shareholders, totally unacceptable. i think we all being taken to the cleaners.dave
my question is can you fault them for raising money over a year ago at about 10 dollars, diluting the stock and then doing nothing with the money, this to me is ripping off shareholders, totally unacceptable. i think we all being taken to the cleaners.dave
Q: so knight is turning out be the ultimate dog, everyone including me and 5i is holding knght on the assumption that sooner than later he does a huge deal.
m question is why should we hold it,there are so many great stocks i could buy wth my 12000 shares reduced from 30000 over the last 6 months.
and it is not like he is going to do an amaya deal issuing stock at double its price the day a deal is announced, so i pay 2 dollars more to buy knight when a deals announced,but that could be in years.i feel i am being suckered.
a great money manager that you know said to me about knight, lightning never strikes the same place twice. dave
m question is why should we hold it,there are so many great stocks i could buy wth my 12000 shares reduced from 30000 over the last 6 months.
and it is not like he is going to do an amaya deal issuing stock at double its price the day a deal is announced, so i pay 2 dollars more to buy knight when a deals announced,but that could be in years.i feel i am being suckered.
a great money manager that you know said to me about knight, lightning never strikes the same place twice. dave
Q: GUD keeps decreasing. Do you foresee the stock increasing at some point ?
Q: As always I would value your thoughts on Lexagene. It has been steadily creeping up.
Thanks!
Thanks!
Q: Been in SIS since 6 Thanks to you. Enjoying the ride and how Company has Grown. You were right on for the last acquisition that ended up being for Span America.
Given the Situation that Savaria sits at now. Where do you see their Plans moving ahead. Plus any other small cap companies like how SIS was couple of years ago that you like right now. Thanks. Barry.
Given the Situation that Savaria sits at now. Where do you see their Plans moving ahead. Plus any other small cap companies like how SIS was couple of years ago that you like right now. Thanks. Barry.
Q: You seem to like Covalon a lot and I wonder what you are seeing that it might be worth investing in.
It looks to me that their product line is not very diversified....and a Chinese copycat could easily move in.
If you had a choice between COV,KXS or CLS what would be your pick be in order without looking at sectors?
It looks to me that their product line is not very diversified....and a Chinese copycat could easily move in.
If you had a choice between COV,KXS or CLS what would be your pick be in order without looking at sectors?
Q: Can you please provide your opinion on a long term hold of Hamilton Thorne ($HTL.v) from this level? Currently the company includes the original IVF equipment business, toxicity testing business, and a European full service distribution business.
The company has telegraphed its intention to continue growth by the following:
1. Making meaningful acquisitions with active discussions underway;
2. Organic growth by expanding into new geographies and expanding the breadth of product and service offerings from both internal R&D and adding new 3rd party suppliers on the global platform; and
3. Cross selling between all of the integrated businesses.
It is also at the ~$100M market cap (fully diluted) where both new institutional and retail investors alike will start to take notice.
TIA,
Meredith
The company has telegraphed its intention to continue growth by the following:
1. Making meaningful acquisitions with active discussions underway;
2. Organic growth by expanding into new geographies and expanding the breadth of product and service offerings from both internal R&D and adding new 3rd party suppliers on the global platform; and
3. Cross selling between all of the integrated businesses.
It is also at the ~$100M market cap (fully diluted) where both new institutional and retail investors alike will start to take notice.
TIA,
Meredith
Q: Hello, what are your thoughts on the news regarding a bid for Aetna? Stock is down quite a bit over the past year. I had initially had a 5% weighting, thinking about buying more on the price weakness, Thank you!
Q: Any comments on reactions to news items following the private financing?
Q: I have small position in CELG (about 2%). With the recent weakness in the last week, would you suggest holding onto it, or even buying more? If I were to sell is there another healthcare stock you would suggest?
Q: I use this ETF to provide proper exposure to healthcare within my portfolio. Now it is under pressure as a result of political pressure. Would this be a good time to take profits?
Q: Savaria reports earnings on Nov.8.
What is the outlook? How often did they miss earnings in the past?
Thank you very much.
What is the outlook? How often did they miss earnings in the past?
Thank you very much.
Q: Hi Team,
GSK has been down to 5 year low @$36.52 today. Your comment about pick up some for medium-term hold ?
Thanks as always,
Tak
GSK has been down to 5 year low @$36.52 today. Your comment about pick up some for medium-term hold ?
Thanks as always,
Tak
Q: Hello...your view today on PLI please as a purely speculative purchase...
Q: Could I get your opinion on Amarin, a small cap biotech stock?
Q: You were right about CXR.
I was reading recently that their earnings were improving some and hoping for a small bump before dumping my remaining shares. Looks like I asked one day too late.
Paul
I was reading recently that their earnings were improving some and hoping for a small bump before dumping my remaining shares. Looks like I asked one day too late.
Paul
Q: Is this a good opportunity at this time for a two year hold?
Q: I know you don't cover American stocks but was wondering if I could get your opinion on RAD.